nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—ACVR1B—pancreatic cancer	0.0367	0.0467	CbGpPWpGaD
Framycetin—Ulcerative keratitis—Erlotinib—pancreatic cancer	0.028	0.135	CcSEcCtD
Framycetin—CXCR4—Peptide GPCRs—SSTR3—pancreatic cancer	0.0203	0.0258	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—NDRG1—pancreatic cancer	0.0198	0.0252	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—SSTR1—pancreatic cancer	0.0194	0.0247	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—SSTR2—pancreatic cancer	0.0187	0.0238	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—CCKBR—pancreatic cancer	0.0181	0.023	CbGpPWpGaD
Framycetin—Ototoxicity—Docetaxel—pancreatic cancer	0.0174	0.0835	CcSEcCtD
Framycetin—Impaired healing—Sunitinib—pancreatic cancer	0.0141	0.0681	CcSEcCtD
Framycetin—CXCR4—Peptide GPCRs—CCKAR—pancreatic cancer	0.0135	0.0171	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—PRLHR—pancreatic cancer	0.0112	0.0143	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—SSTR3—pancreatic cancer	0.00953	0.0121	CbGpPWpGaD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—NOTCH1—pancreatic cancer	0.00942	0.012	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—SSTR1—pancreatic cancer	0.00914	0.0116	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—AGTR1—pancreatic cancer	0.00905	0.0115	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—PPY—pancreatic cancer	0.00896	0.0114	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—SSTR2—pancreatic cancer	0.0088	0.0112	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—PRLHR—pancreatic cancer	0.00878	0.0112	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	0.00856	0.0109	CbGpPWpGaD
Framycetin—Nephropathy toxic—Gemcitabine—pancreatic cancer	0.00854	0.0411	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCKBR—pancreatic cancer	0.0085	0.0108	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—SRC—pancreatic cancer	0.00824	0.0105	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—SSTR3—pancreatic cancer	0.00804	0.0102	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—VEGFA—pancreatic cancer	0.00803	0.0102	CbGpPWpGaD
Framycetin—Secondary infection—Epirubicin—pancreatic cancer	0.00799	0.0385	CcSEcCtD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—KDR—pancreatic cancer	0.00799	0.0102	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—SSTR1—pancreatic cancer	0.00771	0.00982	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—PPY—pancreatic cancer	0.00756	0.00963	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—NOTCH1—pancreatic cancer	0.00752	0.00958	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—PRLHR—pancreatic cancer	0.00752	0.00957	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—SSTR3—pancreatic cancer	0.00746	0.0095	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—SSTR2—pancreatic cancer	0.00742	0.00945	CbGpPWpGaD
Framycetin—Secondary infection—Doxorubicin—pancreatic cancer	0.00739	0.0356	CcSEcCtD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—MMP9—pancreatic cancer	0.00734	0.00934	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	0.00733	0.00933	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—SSTR1—pancreatic cancer	0.00716	0.00911	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	0.00701	0.00892	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—SSTR2—pancreatic cancer	0.00689	0.00877	CbGpPWpGaD
Framycetin—Viral infection—Sunitinib—pancreatic cancer	0.00677	0.0326	CcSEcCtD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CCKBR—pancreatic cancer	0.00665	0.00847	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCK—pancreatic cancer	0.00661	0.00841	CbGpPWpGaD
Framycetin—Sensitisation—Epirubicin—pancreatic cancer	0.00658	0.0317	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—SSTR3—pancreatic cancer	0.00639	0.00814	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCKAR—pancreatic cancer	0.00634	0.00806	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—SSTR1—pancreatic cancer	0.00613	0.0078	CbGpPWpGaD
Framycetin—Sensitisation—Doxorubicin—pancreatic cancer	0.00608	0.0293	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatic cancer	0.00601	0.00765	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—SSTR2—pancreatic cancer	0.0059	0.00751	CbGpPWpGaD
Framycetin—Swelling—Tamoxifen—pancreatic cancer	0.00587	0.0283	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—PRLHR—pancreatic cancer	0.00573	0.00729	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCKBR—pancreatic cancer	0.0057	0.00726	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CNR2—pancreatic cancer	0.00543	0.00692	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CXCL8—pancreatic cancer	0.00518	0.0066	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—AKT1—pancreatic cancer	0.00512	0.00652	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—PIK3CG—pancreatic cancer	0.00509	0.00648	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CNR2—pancreatic cancer	0.00504	0.00642	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—SST—pancreatic cancer	0.00501	0.00637	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatic cancer	0.00496	0.00631	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—SSTR3—pancreatic cancer	0.00487	0.0062	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—SSTR1—pancreatic cancer	0.00467	0.00594	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—PPY—pancreatic cancer	0.00458	0.00583	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—SSTR2—pancreatic cancer	0.00449	0.00572	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatic cancer	0.00443	0.00564	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCKBR—pancreatic cancer	0.00434	0.00552	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatic cancer	0.00432	0.0055	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—AGTR1—pancreatic cancer	0.00426	0.00542	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatic cancer	0.00425	0.00541	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—SST—pancreatic cancer	0.00422	0.00538	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—TGFB1—pancreatic cancer	0.00404	0.00514	CbGpPWpGaD
Framycetin—Swelling—Fluorouracil—pancreatic cancer	0.00397	0.0191	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—PIK3CB—pancreatic cancer	0.0039	0.00497	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CNR1—pancreatic cancer	0.0039	0.00496	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	0.00369	0.0047	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CNR1—pancreatic cancer	0.00362	0.00461	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—SCT—pancreatic cancer	0.00354	0.0045	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—MMP9—pancreatic cancer	0.00339	0.00432	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCK—pancreatic cancer	0.00338	0.0043	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	0.00336	0.00428	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—AGTR1—pancreatic cancer	0.00333	0.00424	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CNR2—pancreatic cancer	0.00329	0.00419	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—GLP1R—pancreatic cancer	0.00329	0.00419	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCKAR—pancreatic cancer	0.00324	0.00412	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—SRC—pancreatic cancer	0.00313	0.00398	CbGpPWpGaD
Framycetin—Erythema—Tamoxifen—pancreatic cancer	0.00312	0.015	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.0031	0.00395	CbGpPWpGaD
Framycetin—Erythema—Erlotinib—pancreatic cancer	0.00309	0.0149	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—STAT3—pancreatic cancer	0.00301	0.00384	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—SHH—pancreatic cancer	0.00295	0.00376	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PRLHR—pancreatic cancer	0.00294	0.00374	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—IAPP—pancreatic cancer	0.00291	0.00371	CbGpPWpGaD
Framycetin—CXCR4—islet of Langerhans—pancreatic cancer	0.00287	0.434	CbGeAlD
Framycetin—Swelling—Docetaxel—pancreatic cancer	0.00287	0.0138	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.00286	0.00364	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—PTHLH—pancreatic cancer	0.0028	0.00356	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—PTCH1—pancreatic cancer	0.0028	0.00356	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—SSTR3—pancreatic cancer	0.00275	0.0035	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GDI2—pancreatic cancer	0.00269	0.00343	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GDI1—pancreatic cancer	0.00269	0.00343	CbGpPWpGaD
Framycetin—Erythema—Sunitinib—pancreatic cancer	0.00267	0.0129	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—SSTR1—pancreatic cancer	0.00264	0.00336	CbGpPWpGaD
Framycetin—Viral infection—Epirubicin—pancreatic cancer	0.0026	0.0125	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—PPY—pancreatic cancer	0.00259	0.00329	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—SST—pancreatic cancer	0.00256	0.00326	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—SSTR2—pancreatic cancer	0.00254	0.00323	CbGpPWpGaD
Framycetin—Infection—Tamoxifen—pancreatic cancer	0.00253	0.0122	CcSEcCtD
Framycetin—Infection—Erlotinib—pancreatic cancer	0.0025	0.0121	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—SSTR3—pancreatic cancer	0.0025	0.00318	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCKBR—pancreatic cancer	0.00245	0.00312	CbGpPWpGaD
Framycetin—Viral infection—Doxorubicin—pancreatic cancer	0.00241	0.0116	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—SSTR1—pancreatic cancer	0.0024	0.00305	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—PIK3CA—pancreatic cancer	0.00238	0.00303	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CNR1—pancreatic cancer	0.00236	0.003	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	0.00236	0.003	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PPY—pancreatic cancer	0.00235	0.00299	CbGpPWpGaD
Framycetin—CXCR4—Disease—PRSS1—pancreatic cancer	0.00233	0.00297	CbGpPWpGaD
Framycetin—CXCR4—Disease—ZNRF3—pancreatic cancer	0.00233	0.00297	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—SSTR2—pancreatic cancer	0.00231	0.00294	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—GCG—pancreatic cancer	0.00228	0.0029	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCKBR—pancreatic cancer	0.00223	0.00284	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—AGTR1—pancreatic cancer	0.00218	0.00277	CbGpPWpGaD
Framycetin—Infection—Sunitinib—pancreatic cancer	0.00217	0.0104	CcSEcCtD
Framycetin—Erythema—Gemcitabine—pancreatic cancer	0.00215	0.0103	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—GAST—pancreatic cancer	0.00211	0.00268	CbGpPWpGaD
Framycetin—Erythema—Fluorouracil—pancreatic cancer	0.00211	0.0102	CcSEcCtD
Framycetin—CXCR4—Disease—DTX1—pancreatic cancer	0.00211	0.00268	CbGpPWpGaD
Framycetin—CXCR4—pancreas—pancreatic cancer	0.00202	0.305	CbGeAlD
Framycetin—CXCR4—GPCR downstream signaling—SCT—pancreatic cancer	0.002	0.00255	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCL8—pancreatic cancer	0.00195	0.00248	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—AKT1—pancreatic cancer	0.00194	0.00247	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GAST—pancreatic cancer	0.00192	0.00244	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCK—pancreatic cancer	0.00191	0.00243	CbGpPWpGaD
Framycetin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00188	0.00903	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—CNR2—pancreatic cancer	0.00186	0.00237	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GLP1R—pancreatic cancer	0.00186	0.00237	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCKAR—pancreatic cancer	0.00183	0.00233	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—SCT—pancreatic cancer	0.00182	0.00231	CbGpPWpGaD
Framycetin—Pruritus—Tamoxifen—pancreatic cancer	0.0018	0.00867	CcSEcCtD
Framycetin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.0018	0.00865	CcSEcCtD
Framycetin—Infection—Irinotecan—pancreatic cancer	0.00179	0.00859	CcSEcCtD
Framycetin—Pruritus—Erlotinib—pancreatic cancer	0.00178	0.00858	CcSEcCtD
Framycetin—CXCR4—Disease—DTX4—pancreatic cancer	0.00177	0.00225	CbGpPWpGaD
Framycetin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00175	0.00843	CcSEcCtD
Framycetin—Diarrhoea—Tamoxifen—pancreatic cancer	0.00174	0.00839	CcSEcCtD
Framycetin—Infection—Gemcitabine—pancreatic cancer	0.00174	0.00837	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—PRLHR—pancreatic cancer	0.00174	0.00221	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCK—pancreatic cancer	0.00173	0.0022	CbGpPWpGaD
Framycetin—Diarrhoea—Erlotinib—pancreatic cancer	0.00172	0.0083	CcSEcCtD
Framycetin—CXCR4—digestive system—pancreatic cancer	0.00172	0.261	CbGeAlD
Framycetin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00172	0.00828	CcSEcCtD
Framycetin—CXCR4—Disease—PPP2R5B—pancreatic cancer	0.00172	0.00219	CbGpPWpGaD
Framycetin—Infection—Fluorouracil—pancreatic cancer	0.00171	0.00823	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CNR2—pancreatic cancer	0.00169	0.00215	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GLP1R—pancreatic cancer	0.00169	0.00215	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCKAR—pancreatic cancer	0.00166	0.00211	CbGpPWpGaD
Framycetin—CXCR4—Disease—HEY2—pancreatic cancer	0.00165	0.00211	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—IAPP—pancreatic cancer	0.00165	0.0021	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.00165	0.0021	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ZNRF3—pancreatic cancer	0.00163	0.00208	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ACVR1B—pancreatic cancer	0.00163	0.00208	CbGpPWpGaD
Framycetin—Vomiting—Tamoxifen—pancreatic cancer	0.00162	0.0078	CcSEcCtD
Framycetin—Hypersensitivity—Sunitinib—pancreatic cancer	0.00161	0.00774	CcSEcCtD
Framycetin—Vomiting—Erlotinib—pancreatic cancer	0.0016	0.00771	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—PTHLH—pancreatic cancer	0.00158	0.00201	CbGpPWpGaD
Framycetin—Pruritus—Sunitinib—pancreatic cancer	0.00154	0.00743	CcSEcCtD
Framycetin—CXCR4—Disease—HEY1—pancreatic cancer	0.00153	0.00195	CbGpPWpGaD
Framycetin—Erythema—Docetaxel—pancreatic cancer	0.00152	0.00733	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—SHH—pancreatic cancer	0.00151	0.00193	CbGpPWpGaD
Framycetin—Nausea—Tamoxifen—pancreatic cancer	0.00151	0.00728	CcSEcCtD
Framycetin—Nausea—Erlotinib—pancreatic cancer	0.0015	0.00721	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—IAPP—pancreatic cancer	0.0015	0.0019	CbGpPWpGaD
Framycetin—Diarrhoea—Sunitinib—pancreatic cancer	0.00149	0.00719	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—SSTR3—pancreatic cancer	0.00148	0.00188	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—DTX1—pancreatic cancer	0.00148	0.00188	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—SST—pancreatic cancer	0.00145	0.00184	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PTHLH—pancreatic cancer	0.00144	0.00183	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PTCH1—pancreatic cancer	0.00144	0.00183	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SSTR1—pancreatic cancer	0.00142	0.0018	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PPY—pancreatic cancer	0.00139	0.00177	CbGpPWpGaD
Framycetin—Vomiting—Sunitinib—pancreatic cancer	0.00139	0.00668	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—SSTR2—pancreatic cancer	0.00136	0.00173	CbGpPWpGaD
Framycetin—CXCR4—Disease—JAG2—pancreatic cancer	0.00136	0.00173	CbGpPWpGaD
Framycetin—CXCR4—Disease—MEN1—pancreatic cancer	0.00134	0.0017	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CNR1—pancreatic cancer	0.00133	0.0017	CbGpPWpGaD
Framycetin—CXCR4—Disease—SLC2A2—pancreatic cancer	0.00133	0.00169	CbGpPWpGaD
Framycetin—Hypersensitivity—Irinotecan—pancreatic cancer	0.00132	0.00637	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CCKBR—pancreatic cancer	0.00132	0.00167	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—SST—pancreatic cancer	0.00131	0.00167	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.00131	0.00167	CbGpPWpGaD
Framycetin—Nausea—Sunitinib—pancreatic cancer	0.0013	0.00624	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—GCG—pancreatic cancer	0.00129	0.00164	CbGpPWpGaD
Framycetin—CXCR4—Disease—SHH—pancreatic cancer	0.00128	0.00163	CbGpPWpGaD
Framycetin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00127	0.0061	CcSEcCtD
Framycetin—CXCR4—Disease—IAPP—pancreatic cancer	0.00126	0.00161	CbGpPWpGaD
Framycetin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00124	0.00598	CcSEcCtD
Framycetin—Pruritus—Gemcitabine—pancreatic cancer	0.00124	0.00596	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—GLI1—pancreatic cancer	0.00124	0.00157	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—DTX4—pancreatic cancer	0.00124	0.00157	CbGpPWpGaD
Framycetin—Infection—Docetaxel—pancreatic cancer	0.00123	0.00594	CcSEcCtD
Framycetin—Diarrhoea—Irinotecan—pancreatic cancer	0.00123	0.00592	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—AGTR1—pancreatic cancer	0.00123	0.00156	CbGpPWpGaD
Framycetin—Pruritus—Fluorouracil—pancreatic cancer	0.00122	0.00586	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CNR1—pancreatic cancer	0.00121	0.00154	CbGpPWpGaD
Framycetin—CXCR4—Disease—HSPA1B—pancreatic cancer	0.00121	0.00154	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NRP1—pancreatic cancer	0.0012	0.00153	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PPP2R5B—pancreatic cancer	0.0012	0.00153	CbGpPWpGaD
Framycetin—Diarrhoea—Gemcitabine—pancreatic cancer	0.0012	0.00577	CcSEcCtD
Framycetin—Diarrhoea—Fluorouracil—pancreatic cancer	0.00118	0.00567	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—GCG—pancreatic cancer	0.00117	0.00149	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HEY2—pancreatic cancer	0.00116	0.00147	CbGpPWpGaD
Framycetin—Vomiting—Irinotecan—pancreatic cancer	0.00114	0.0055	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—GAST—pancreatic cancer	0.00113	0.00144	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AGTR1—pancreatic cancer	0.00112	0.00142	CbGpPWpGaD
Framycetin—Vomiting—Gemcitabine—pancreatic cancer	0.00111	0.00536	CcSEcCtD
Framycetin—Vomiting—Fluorouracil—pancreatic cancer	0.00109	0.00527	CcSEcCtD
Framycetin—CXCR4—Disease—JAG1—pancreatic cancer	0.00108	0.00138	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SCT—pancreatic cancer	0.00107	0.00137	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HEY1—pancreatic cancer	0.00107	0.00137	CbGpPWpGaD
Framycetin—Nausea—Irinotecan—pancreatic cancer	0.00107	0.00514	CcSEcCtD
Framycetin—Nausea—Gemcitabine—pancreatic cancer	0.00104	0.00501	CcSEcCtD
Framycetin—CXCR4—Disease—CD44—pancreatic cancer	0.00103	0.00131	CbGpPWpGaD
Framycetin—Erythema—Epirubicin—pancreatic cancer	0.00103	0.00494	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CCK—pancreatic cancer	0.00102	0.0013	CbGpPWpGaD
Framycetin—Nausea—Fluorouracil—pancreatic cancer	0.00102	0.00492	CcSEcCtD
Framycetin—CXCR4—Disease—HSPA1A—pancreatic cancer	0.00102	0.0013	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CNR2—pancreatic cancer	0.000997	0.00127	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GLP1R—pancreatic cancer	0.000997	0.00127	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL8—pancreatic cancer	0.000997	0.00127	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCKAR—pancreatic cancer	0.000981	0.00125	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—JAG2—pancreatic cancer	0.000951	0.00121	CbGpPWpGaD
Framycetin—Erythema—Doxorubicin—pancreatic cancer	0.00095	0.00457	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—MEN1—pancreatic cancer	0.000938	0.00119	CbGpPWpGaD
Framycetin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000915	0.00441	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—SHH—pancreatic cancer	0.000894	0.00114	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOTCH4—pancreatic cancer	0.000889	0.00113	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IAPP—pancreatic cancer	0.000883	0.00112	CbGpPWpGaD
Framycetin—Pruritus—Docetaxel—pancreatic cancer	0.000879	0.00423	CcSEcCtD
Framycetin—Diarrhoea—Docetaxel—pancreatic cancer	0.00085	0.00409	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—PTCH1—pancreatic cancer	0.000848	0.00108	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTHLH—pancreatic cancer	0.000848	0.00108	CbGpPWpGaD
Framycetin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000838	0.00403	CcSEcCtD
Framycetin—Infection—Epirubicin—pancreatic cancer	0.000832	0.00401	CcSEcCtD
Framycetin—CXCR4—Disease—SMAD4—pancreatic cancer	0.000813	0.00103	CbGpPWpGaD
Framycetin—CXCR4—Disease—HES1—pancreatic cancer	0.000794	0.00101	CbGpPWpGaD
Framycetin—Vomiting—Docetaxel—pancreatic cancer	0.00079	0.0038	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—SST—pancreatic cancer	0.000776	0.000987	CbGpPWpGaD
Framycetin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000775	0.00373	CcSEcCtD
Framycetin—Infection—Doxorubicin—pancreatic cancer	0.00077	0.00371	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000765	0.000974	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—JAG1—pancreatic cancer	0.000759	0.000966	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOTCH3—pancreatic cancer	0.000756	0.000962	CbGpPWpGaD
Framycetin—Nausea—Docetaxel—pancreatic cancer	0.000738	0.00355	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CNR1—pancreatic cancer	0.000716	0.000911	CbGpPWpGaD
Framycetin—CXCR4—Disease—TERT—pancreatic cancer	0.000695	0.000885	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000695	0.000884	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GCG—pancreatic cancer	0.000691	0.00088	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000672	0.000856	CbGpPWpGaD
Framycetin—CXCR4—Disease—HIF1A—pancreatic cancer	0.000665	0.000847	CbGpPWpGaD
Framycetin—CXCR4—Disease—TSC2—pancreatic cancer	0.000663	0.000844	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AGTR1—pancreatic cancer	0.000659	0.000839	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—STK11—pancreatic cancer	0.00065	0.000827	CbGpPWpGaD
Framycetin—CXCR4—Disease—APOE—pancreatic cancer	0.000649	0.000826	CbGpPWpGaD
Framycetin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000617	0.00297	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000611	0.000777	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOTCH1—pancreatic cancer	0.000599	0.000763	CbGpPWpGaD
Framycetin—Pruritus—Epirubicin—pancreatic cancer	0.000593	0.00285	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000586	0.000746	CbGpPWpGaD
Framycetin—CXCR4—Disease—EGF—pancreatic cancer	0.000579	0.000737	CbGpPWpGaD
Framycetin—Diarrhoea—Epirubicin—pancreatic cancer	0.000573	0.00276	CcSEcCtD
Framycetin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000571	0.00275	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—SMAD4—pancreatic cancer	0.000569	0.000725	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000563	0.000717	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HES1—pancreatic cancer	0.000556	0.000707	CbGpPWpGaD
Framycetin—Pruritus—Doxorubicin—pancreatic cancer	0.000549	0.00264	CcSEcCtD
Framycetin—Vomiting—Epirubicin—pancreatic cancer	0.000533	0.00256	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000532	0.000677	CbGpPWpGaD
Framycetin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000531	0.00255	CcSEcCtD
Framycetin—CXCR4—Disease—PIK3CD—pancreatic cancer	0.000515	0.000656	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL8—pancreatic cancer	0.000511	0.000651	CbGpPWpGaD
Framycetin—Nausea—Epirubicin—pancreatic cancer	0.000498	0.0024	CcSEcCtD
Framycetin—Vomiting—Doxorubicin—pancreatic cancer	0.000493	0.00237	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—TERT—pancreatic cancer	0.000487	0.00062	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HIF1A—pancreatic cancer	0.000466	0.000593	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TSC2—pancreatic cancer	0.000465	0.000591	CbGpPWpGaD
Framycetin—Nausea—Doxorubicin—pancreatic cancer	0.000461	0.00222	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—APOE—pancreatic cancer	0.000455	0.000579	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CB—pancreatic cancer	0.000449	0.000571	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KDR—pancreatic cancer	0.000445	0.000567	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTGS2—pancreatic cancer	0.000445	0.000566	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NFKBIA—pancreatic cancer	0.000424	0.000539	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOTCH1—pancreatic cancer	0.00042	0.000534	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CG—pancreatic cancer	0.00041	0.000522	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—NRAS—pancreatic cancer	0.00041	0.000522	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EGF—pancreatic cancer	0.000406	0.000516	CbGpPWpGaD
Framycetin—CXCR4—Disease—CTNNB1—pancreatic cancer	0.000398	0.000507	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTEN—pancreatic cancer	0.000388	0.000494	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—EGFR—pancreatic cancer	0.000374	0.000476	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CD—pancreatic cancer	0.000361	0.000459	CbGpPWpGaD
Framycetin—CXCR4—Disease—SRC—pancreatic cancer	0.00036	0.000458	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000357	0.000455	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—KRAS—pancreatic cancer	0.000353	0.00045	CbGpPWpGaD
Framycetin—CXCR4—Disease—STAT3—pancreatic cancer	0.000347	0.000442	CbGpPWpGaD
Framycetin—CXCR4—Disease—NRAS—pancreatic cancer	0.000346	0.000441	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000324	0.000413	CbGpPWpGaD
Framycetin—CXCR4—Disease—MYC—pancreatic cancer	0.000322	0.00041	CbGpPWpGaD
Framycetin—CXCR4—Disease—TGFB1—pancreatic cancer	0.000322	0.000409	CbGpPWpGaD
Framycetin—CXCR4—Disease—EGFR—pancreatic cancer	0.000315	0.000401	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CB—pancreatic cancer	0.000314	0.0004	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL8—pancreatic cancer	0.000302	0.000385	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HRAS—pancreatic cancer	0.0003	0.000382	CbGpPWpGaD
Framycetin—CXCR4—Disease—KRAS—pancreatic cancer	0.000298	0.000379	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AKT1—pancreatic cancer	0.000292	0.000372	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CASP3—pancreatic cancer	0.000289	0.000368	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCND1—pancreatic cancer	0.000281	0.000358	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CTNNB1—pancreatic cancer	0.000279	0.000355	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CA—pancreatic cancer	0.000274	0.000348	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MMP9—pancreatic cancer	0.000273	0.000348	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTEN—pancreatic cancer	0.000272	0.000346	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AKT1—pancreatic cancer	0.000265	0.000337	CbGpPWpGaD
Framycetin—CXCR4—Disease—HRAS—pancreatic cancer	0.000253	0.000322	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SRC—pancreatic cancer	0.000252	0.000321	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VEGFA—pancreatic cancer	0.000245	0.000312	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—STAT3—pancreatic cancer	0.000243	0.000309	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NRAS—pancreatic cancer	0.000242	0.000309	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MYC—pancreatic cancer	0.000226	0.000287	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TGFB1—pancreatic cancer	0.000225	0.000287	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKT1—pancreatic cancer	0.000224	0.000285	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EGFR—pancreatic cancer	0.000221	0.000281	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KRAS—pancreatic cancer	0.000209	0.000266	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CA—pancreatic cancer	0.000192	0.000244	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TP53—pancreatic cancer	0.000185	0.000236	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HRAS—pancreatic cancer	0.000177	0.000226	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKT1—pancreatic cancer	0.000157	0.000199	CbGpPWpGaD
